Back to Trades
Other4
Avalyn Pharma Inc.
AVLN
Total Value
$0
Company Information
- Company Name
- Avalyn Pharma Inc.
- Ticker Symbol
- AVLN
- CIK
- 0001540171
Insider Information
- Name
- FMR LLC
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- May 5, 2026
- Transaction Date
- May 1, 2026
- Accession Number
- 0001193125-26-205201
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | 727,585 | — | C | — |
| May 1, 2026 | Common Stock | 80,291 | — | C | — |
| May 1, 2026 | Common Stock | 872,868 | — | C | — |
| May 1, 2026 | Common Stock | 225,843 | — | C | — |
| May 1, 2026 | Common Stock | 377,948 | — | C | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Derivative | 727,585 | — | C | — |
| May 1, 2026 | Derivative | 80,291 | — | C | — |
| May 1, 2026 | Derivative | 872,868 | — | C | — |
| May 1, 2026 | Derivative | 225,843 | — | C | — |
| May 1, 2026 | Derivative | 377,948 | — | C | — |
Footnotes
- (F1)On May 1, 2026, in connection with the completion of the issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock converted on a 1-for-1 basis into shares of Common Stock.